Vaccines against Emerging and Neglected Infectious Diseases: An Overview
Larissa Vuitika, Wasim Aluísio Prates-Syed, Jaqueline Dinis Queiroz Silva, Karin P. Crema, Nelson Côrtes, Aline Lira, Julia Beatriz Menuci Lima, Niels Olsen Saraiva Câmara, Lena F. Schimke, Otávio Cabral-Marques, Mohammad Sadraeian, Lorena C. S. Chaves, Gustavo Cabral‐Miranda
Abstract
Neglected Tropical Diseases (NTDs) are a group of diseases that are highly prevalent in tropical and subtropical regions, and closely associated with poverty and marginalized populations. Infectious diseases affect over 1.6 billion people annually, and vaccines are the best prophylactic tool against them. Along with NTDs, emerging and reemerging infectious diseases also threaten global public health, as they can unpredictably result in pandemics. The recent advances in vaccinology allowed the development and licensing of new vaccine platforms that can target and prevent these diseases. In this work, we discuss the advances in vaccinology and some of the difficulties found in the vaccine development pipeline for selected NTDs and emerging and reemerging infectious diseases, including HIV, Dengue, Ebola, Chagas disease, malaria, leishmaniasis, zika, and chikungunya.